Literature DB >> 28847281

Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.

Winnie Qian1, Corinne E Fischer1, Tom A Schweizer1, David G Munoz1.   

Abstract

BACKGROUND: Psychosis is a common phenomenon in Alzheimer's disease (AD). The APOE ε4 allele is the strongest genetic risk factor for the development of AD, but its association with psychosis remains unclear.
OBJECTIVE: We investigated the associations between psychosis, subdivided into delusions and hallucinations, as well as APOE ε4 allele on cognitive and functional outcomes. Secondarily, we investigated the associations between APOE ε4, Lewy bodies, and psychosis.
METHODS: Data from the National Alzheimer's Coordinating Center (NACC) were used. Nine hundred patients with a confirmed diagnosis of AD based on the NIA-AA Reagan were included in the analysis. Global cognition was assessed using the Mini-Mental State Exam (MMSE) and functional status was assessed using the Functional Activities Questionnaire (FAQ). Psychosis status was determined using the Neuropsychiatric Inventory Questionnaire (NPI-Q). Factorial design was used to assess the effects of psychosis and APOE ε4, as well as their interaction.
RESULTS: Psychosis and the presence of APOE ε4 were both associated with lower MMSE scores, while only psychosis was associated with higher FAQ scores. Furthermore, patients with hallucinations had lower MMSE and higher FAQ scores than patients with only delusions. There was a significant interaction effect between psychosis and APOE ε4 on MMSE scores, with APOE ε4 negatively affecting patients with hallucinations-only psychosis. APOE ε4 was positively associated with the presence of Lewy body pathology, and both were found to be more prevalent in psychotic patients, with a stronger association with hallucinations.
CONCLUSION: Psychosis in AD was associated with greater cognitive and functional impairments. Patients with hallucinations-with or without delusions-conferred even greater deficits compared to patients with only delusions. The APOE ε4 allele was associated with worse cognition, especially for patients with hallucination-only psychosis. APOE ε4 may mediate cognitive impairment in the hallucinations phenotype through the development of Lewy bodies. Our findings support that subtypes of psychosis should be evaluated separately. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  APOE; Alzheimer's disease; Delusions; cognition; hallucinations; lewy bodies; neuropathology; psychosis

Mesh:

Substances:

Year:  2018        PMID: 28847281      PMCID: PMC6211852          DOI: 10.2174/1567205014666170829114346

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  60 in total

1.  Cognitive and behavioural predictors of survival in Alzheimer disease: results from a sample of treated patients in a tertiary-referral memory clinic.

Authors:  Tom C Russ; G David Batty; John M Starr
Journal:  Int J Geriatr Psychiatry       Date:  2011-09-29       Impact factor: 3.485

2.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Marilyn Albert; Georgios Hadjigeorgiou; Alexandros Papadimitriou; Bruno Dubois; Maria Sarazin; Davangere Devanand; Lawrence Honig; Karen Marder; Karen Bell; Domonick Wegesin; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2005-10

Review 3.  Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.

Authors:  Susan A Ropacki; Dilip V Jeste
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

Review 4.  Aging-related diagnostic variations: need for diagnostic criteria appropriate for elderly psychiatric patients.

Authors:  Dilip V Jeste; Dan G Blazer; Michael First
Journal:  Biol Psychiatry       Date:  2005-08-15       Impact factor: 13.382

5.  Clinical and neuropathological findings in Lewy body dementias.

Authors:  D Galasko; R Katzman; D P Salmon; L Hansen
Journal:  Brain Cogn       Date:  1996-07       Impact factor: 2.310

6.  Genetics of Psychosis in Alzheimer Disease.

Authors:  Mary Ann A DeMichele-Sweet; Robert A Sweet
Journal:  Curr Genet Med Rep       Date:  2014-03

7.  Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype.

Authors:  Drew Christie; Jane Shofer; Steven P Millard; Ellen Li; Mary Ann Demichele-Sweet; Elise A Weamer; M Ilyas Kamboh; Oscar L Lopez; Robert A Sweet; Debby Tsuang
Journal:  Behav Brain Funct       Date:  2012-12-27       Impact factor: 3.759

8.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

9.  Psychosis in Alzheimer's disease in the national Alzheimer's disease coordinating center uniform data set: clinical correlates and association with apolipoprotein e.

Authors:  Mary Ann A Demichele-Sweet; Oscar L Lopez; Robert A Sweet
Journal:  Int J Alzheimers Dis       Date:  2011-03-23

10.  Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease.

Authors:  Kristina F Zdanys; Timothy G Kleiman; Martha G MacAvoy; Benjamin T Black; Tracy E Rightmer; Monique Grey; Katherine S Garman; Rajesh R Tampi; Joel Gelernter; Christopher H van Dyck
Journal:  Neuropsychopharmacology       Date:  2006-07-12       Impact factor: 7.853

View more
  6 in total

1.  The neural signatures of psychoses in Alzheimer's disease: a neuroimaging genetics approach.

Authors:  Riccardo Manca; Antonio F Pardiñas; Annalena Venneri
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-21       Impact factor: 5.270

Review 2.  Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.

Authors:  Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2022-01-04       Impact factor: 44.711

Review 3.  Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer's Disease.

Authors:  Reena T Gottesman; Yaakov Stern
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

4.  Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease.

Authors:  Byron Creese; Evangelos Vassos; Sverre Bergh; Lavinia Athanasiu; Iskandar Johar; Arvid Rongve; Ingrid Tøndel Medbøen; Miguel Vasconcelos Da Silva; Eivind Aakhus; Fred Andersen; Francesco Bettella; Anne Braekhus; Srdjan Djurovic; Giulia Paroni; Petroula Proitsi; Ingvild Saltvedt; Davide Seripa; Eystein Stordal; Tormod Fladby; Dag Aarsland; Ole A Andreassen; Clive Ballard; Geir Selbaek
Journal:  Transl Psychiatry       Date:  2019-10-22       Impact factor: 6.222

5.  Molecular subtyping of Alzheimer's disease using RNA sequencing data reveals novel mechanisms and targets.

Authors:  Ryan A Neff; Minghui Wang; Sezen Vatansever; Lei Guo; Chen Ming; Qian Wang; Erming Wang; Emrin Horgusluoglu-Moloch; Won-Min Song; Aiqun Li; Emilie L Castranio; Julia Tcw; Lap Ho; Alison Goate; Valentina Fossati; Scott Noggle; Sam Gandy; Michelle E Ehrlich; Pavel Katsel; Eric Schadt; Dongming Cai; Kristen J Brennand; Vahram Haroutunian; Bin Zhang
Journal:  Sci Adv       Date:  2021-01-06       Impact factor: 14.957

Review 6.  Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.

Authors:  Lilah Besser; Walter Kukull; David S Knopman; Helena Chui; Douglas Galasko; Sandra Weintraub; Gregory Jicha; Cynthia Carlsson; Jeffrey Burns; Joseph Quinn; Robert A Sweet; Katya Rascovsky; Merilee Teylan; Duane Beekly; George Thomas; Mark Bollenbeck; Sarah Monsell; Charles Mock; Xiao Hua Zhou; Nicole Thomas; Elizabeth Robichaud; Margaret Dean; Janene Hubbard; Mary Jacka; Kristen Schwabe-Fry; Joylee Wu; Creighton Phelps; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.